These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6296017)

  • 21. Ceftizoxime: clinical evaluation of efficacy and safety in the U.S.A.
    Parks D; Layne P; Uri J; Ziv D; Bass S
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():327-38. PubMed ID: 6296027
    [No Abstract]   [Full Text] [Related]  

  • 22. Ceftizoxime in the treatment of urinary tract infection in spinal cord injury patients: comparison with tobramycin.
    Montgomerie JZ; Morrow JW; Canawati HN; Gilmore DS; Jiminez EM; Malik GM
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():247-52. PubMed ID: 6296015
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ceftizoxime in the treatment of infective pathology in the elderly].
    Garotta F; Magni O; Meinardi G
    Boll Chim Farm; 1986 Dec; 125(12):127S-131S. PubMed ID: 3473994
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients.
    Yangco BG; Baird I; Lorber B; Noble R; Bermudez R; Silverblatt F; Vasquez G
    J Antimicrob Chemother; 1987 Feb; 19(2):239-48. PubMed ID: 3553135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ceftizoxime in the treatment of urinary tract and respiratory infections in liver disease patients].
    Esposito S; Galante D; Barba D
    G Ital Chemioter; 1985; 32(2):361-5. PubMed ID: 3869114
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical experience with cefamandole in bacterial infections of children (author's transl)].
    Ichioka T; Miyao M
    Jpn J Antibiot; 1979 Sep; 32(9):901-4. PubMed ID: 501918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies of the efficacy and tolerance of cefotaxime, ceftizoxime and ceftriaxone in patients with complicated urinary tract infections].
    Westenfelder M; Pelz K
    Infection; 1983; 11(6):296-301. PubMed ID: 6321356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of cefuzonam (CZON) with cefotiam in bacterial pneumonia and pulmonary suppuration].
    Soejima R; Matsushima T; Niki Y; Kawane H; Kawanishi M; Watanabe M; Hino J; Nakagawa Y; Umeki S; Sumi M
    Kansenshogaku Zasshi; 1986 Aug; 60(8):885-910. PubMed ID: 3098872
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of ceftizoxime compared with that of cefamandole.
    Neu HC; Srinivasan S
    Antimicrob Agents Chemother; 1981 Sep; 20(3):366-9. PubMed ID: 6272631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats.
    Marre R; Herhahn D; Schulz E; Freiesleben H; Sack K
    Infection; 1983; 11 Suppl 1():S54-6. PubMed ID: 6299968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Ceftizoxime in the treatment of urinary tract infections.
    Lentnek AL
    J Urol; 1984 Jan; 131(1):127. PubMed ID: 6317899
    [No Abstract]   [Full Text] [Related]  

  • 33. Cefamandole and cefazolin in the therapy of complicated urinary tract infections.
    Hoyme U; Madsen PO
    J Infect Dis; 1978 May; 137 Suppl():S100-S102. PubMed ID: 349091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of cefamandole in infants and children (author's transl)].
    Kuno K; Nishikawa K; Ogawa A; Yamaguchi H; Koide T; Kondo K
    Jpn J Antibiot; 1979 Sep; 32(9):952-5. PubMed ID: 387995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fundamental and clinical studies of cefamandole sodium in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1979 Sep; 32(9):912-29. PubMed ID: 387994
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of ceftriaxone versus cefotaxime for childhood upper urinary tract infections.
    Bakkaloglu A; Saatci U; Soylemezoglu O; Ozen S; Topaloglu R; Besbas N; Saatci I
    J Chemother; 1996 Feb; 8(1):59-62. PubMed ID: 8835111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of cefamandole: a new cephalosporin.
    Little PJ; Peddie BA; Pearson S
    Med J Aust; 1979 Feb; 1(3):97-9. PubMed ID: 431451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical evaluation of cefamandole on urinary tract and genital organ infections (author's transl)].
    Doi S; Fujimoto A; Ito M; Sugimoto O; Tsujii K
    Jpn J Antibiot; 1980 Apr; 33(4):411-5. PubMed ID: 6997528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.
    Nichols RL; Wikler MA; McDevitt JT; Lentnek AL; Hosutt JA
    Antimicrob Agents Chemother; 1987 Feb; 31(2):281-5. PubMed ID: 3471181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical effect of ceftizoxime suppositories].
    Kuramitsu M; Morioka N; Morita H; Wakiguchi H; Ogura H; Kurashige T; Kitamura I
    Jpn J Antibiot; 1985 Oct; 38(10):2962-9. PubMed ID: 2934562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.